-transparent.png){kind=logo}
From literature data and their own experience, the authors comment hematological complications, related to the use of D-penicillamine, mainly in theumatoïd arthritis. Hypereosinophilia is more common than thrombopenia, but, both complications are usually benign. Anemia alone is very rare. Leukopenia appears in 6% of treated patients, but pancytopenia is rare. Leukopenia and pancytopenia are the most severe complications, even fatal in some cases. The safest dose of D-penicillamine seems to be between 600 and 900 mg per day, provided that, however, regular hematological controls may be achieved.
Related Publications
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
December 1975,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
February 1977,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
November 1973,
Munchener medizinische Wochenschrift (1950),
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
May 1981,
La Nouvelle presse medicale,
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
November 1977,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
July 1976,
Deutsche medizinische Wochenschrift (1946),
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
January 1986,
Indian journal of pediatrics,
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
January 1979,
Harefuah,
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
January 1981,
Therapie,
J L Franck, and
G Bouteiller, and
M Gayrard, and
J Arlet
April 1984,
Annals of the rheumatic diseases,
